Emergent BioSolutions (NYSE:EBS) Coverage Initiated by Analysts at HC Wainwright
HC Wainwright began coverage on shares of Emergent BioSolutions (NYSE:EBS – Free Report) in a research note issued to investors on Monday, Marketbeat reports. The brokerage issued a buy rating and a $15.00 price objective on the biopharmaceutical company’s stock. Other equities research analysts have also issued research reports about the stock. StockNews.com lowered shares […]
More Stories
Blue Barn Wealth LLC Has $384,000 Position in Alphabet Inc. (NASDAQ:GOOGL)
Blue Barn Wealth LLC lowered its position in Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 8.3% in the 1st quarter,...
Gemini Chatbot Got a New Update: Enhanced Memory with New Privacy Options
Google is coming up with new updates to its Gemini AI assistant that aim to make conversations more personal and...
PNC Financial Services Group Inc. Has $472,000 Stock Position in CAVA Group, Inc. (NYSE:CAVA)
PNC Financial Services Group Inc. raised its position in CAVA Group, Inc. (NYSE:CAVA – Free Report) by 123.4% during the...
Alphabet Inc. (NASDAQ:GOOGL) Shares Sold by VeraBank N.A.
VeraBank N.A. decreased its holdings in shares of Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 0.8% during the 1st quarter,...
Alphabet Inc. (NASDAQ:GOOGL) Shares Sold by Arjuna Capital
Arjuna Capital lowered its stake in Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 1.6% in the 1st quarter, according to...
Alphabet Inc. (NASDAQ:GOOGL) Position Boosted by CenterBook Partners LP
CenterBook Partners LP boosted its stake in shares of Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 43.8% during the 1st...